Zobrazeno 1 - 10
of 12
pro vyhledávání: '"K. Akaya Smith"'
Autor:
Jeff Min, Dina H. Appleby, Robyn L. McClelland, Jasleen Minhas, John H. Holmes, Ryan J. Urbanowicz, Steven C. Pugliese, Jeremy A. Mazurek, K. Akaya Smith, Jason S. Fritz, Harold I. Palevsky, Jude Moutchia Suh, Nadine Al-Naamani, Steven M. Kawut
Publikováno v:
Ann Am Thorac Soc
RATIONALE: The population of patients with pulmonary arterial hypertension (PAH) has evolved over time from predominantly young White women to an older, more racially diverse and obese population. Whether these changes are reflected in clinical trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67fa1dcaf0551e00103fc4995fca500d
https://pubmed.ncbi.nlm.nih.gov/34936541
https://pubmed.ncbi.nlm.nih.gov/34936541
Autor:
Breanne E. McCarthy, Robyn L. McClelland, Dina H. Appleby, Jude S. Moutchia, Jasleen K. Minhas, Jeff Min, Jeremy A. Mazurek, K. Akaya Smith, Jason S. Fritz, Steven C. Pugliese, Ryan J. Urbanowicz, John H. Holmes, Harold I. Palevsky, Steven M. Kawut, Nadine Al-Naamani
Publikováno v:
Chest. 162:436-447
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d98f2fea786a61af198b1d6111812198
https://doi.org/10.1016/j.chest.2022.02.041
https://doi.org/10.1016/j.chest.2022.02.041
Autor:
Breanne E, McCarthy, Robyn L, McClelland, Dina H, Appleby, Jude S, Moutchia, Jasleen K, Minhas, Jeff, Min, Jeremy A, Mazurek, K Akaya, Smith, Jason S, Fritz, Steven C, Pugliese, Ryan J, Urbanowicz, John H, Holmes, Harold I, Palevsky, Steven M, Kawut, Nadine, Al-Naamani
Publikováno v:
Chest. 162(2)
Obesity is increasingly prevalent in pulmonary arterial hypertension (PAH) but is associated with improved survival, creating an "obesity paradox" in PAH. It is unknown if the improved outcomes could be attributable to obese patients deriving a great
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9bc1cc326d2cc43500cad1194a910f00
https://pubmed.ncbi.nlm.nih.gov/35247393
https://pubmed.ncbi.nlm.nih.gov/35247393
Autor:
Jeremy A. Mazurek, Harold I. Palevsky, David A. Mankoff, Margaret R. MacLean, Angela DeMichele, Margaret F. Doyle, Diane Pinder, Steven M. Kawut, Nadine Al-Naamani, Jason S. Fritz, Amber McCormick, K. Akaya Smith
Publikováno v:
Ann Am Thorac Soc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1812779cf8721c9e618c2f617b078e
https://doi.org/10.1513/annalsats.201904-328rl
https://doi.org/10.1513/annalsats.201904-328rl
Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial
Autor:
Harold I. Palevsky, Corey E. Ventetuolo, James R. Klinger, Kathleen J. Propert, Frank Z. Stanczyk, Anjali Vaidya, Mary Whittenhall, Amy Palmisciano, M. Patel, Diane Pinder, Bonnie Ky, Russell P. Tracy, K. Akaya Smith, Angela DeMichele, Jason S. Fritz, Steven M. Kawut, Christine Archer-Chicko
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 195:360-368
Rationale: The aromatase inhibitor anastrozole blocks the conversion of androgens to estrogen and blunts pulmonary hypertension in animals, but its efficacy in treating patients with pulmonary arterial hypertension (PAH) is unknown.Objectives: We aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::260c439bfaf8ff66c36963f9518a7c8f
https://doi.org/10.1164/rccm.201605-1024oc
https://doi.org/10.1164/rccm.201605-1024oc
Autor:
K. Akaya Smith, Jason S. Fritz
Publikováno v:
Chest. 150:705-713
Pulmonary hypertension (PH) is an increasingly recognized cause of morbidity and mortality, and in the past 20 years, there has been a rapid expansion in research and available therapies. Although it is defined quite simply as a mean pulmonary arteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8702fc52f6ea22a1aae9b322d17d24b
https://doi.org/10.1016/j.chest.2016.05.010
https://doi.org/10.1016/j.chest.2016.05.010
Autor:
Haochang Shou, Christine Archer-Chicko, Harold I. Palevsky, Diane Pinder, Marilyn S. Sommers, Anjali Vaidya, Steven M. Kawut, Danielle Dubow, Lea Ann Matura, K. Akaya Smith, Jason S. Fritz
Publikováno v:
Chest. 150:46-56
Background Fatigue is a common symptom in patients with pulmonary arterial hypertension (PAH); however, the impact of fatigue on daily physical activity in PAH is unknown. Accelerometry is a validated measure for assessing physical activity. We hypot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92798a7df9d9382205ca8ac113ea4d37
https://doi.org/10.1016/j.chest.2016.02.633
https://doi.org/10.1016/j.chest.2016.02.633
Autor:
Diane Pinder, Amy J. Palmisicano, R. Graham Barr, Joao A.C. Lima, Harold I. Palevsky, Steven M. Kawut, Christopher J Mullin, Christine Archer-Chicko, Andrew Foderaro, David A. Bluemke, Grayson L. Baird, James R. Klinger, Thomas Walsh, Ioana R. Preston, Pamela Ouyang, Jason S. Fritz, Kari E. Roberts, Nicholas S. Hill, Corey E. Ventetuolo, K. Akaya Smith, Mary Whittenhall
Publikováno v:
The European respiratory journal. 51(6)
High oestradiol (E2) and low dehydroepiandrosterone-sulfate (DHEA-S) levels are risk factors for pulmonary arterial hypertension (PAH) in men, but whether sex hormones are related to PAH in women is unknown.Post-menopausal women aged ≥55 years with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac060b60aeb786bce6f38f5441231bee
https://pubmed.ncbi.nlm.nih.gov/29954927
https://pubmed.ncbi.nlm.nih.gov/29954927
Autor:
Jonathan N. Menachem, Gregory S. Troutman, Julio A. Chirinos, Edo Y. Birati, E. Wilson Grandin, K. Akaya Smith, Payman Zamani, Steven M. Kawut, Anjali Vaidya, Jeremy A. Mazurek, Priyanka Bhattacharya, Paul R. Forfia, Stuart B. Prenner
Publikováno v:
Journal of Cardiac Failure. 25:S65
Background Pulmonary hypertension (PH) in the setting of left heart disease (PH-LHD) is the most common cause of PH in the general population, with a prevalence of up to 80% and is associated with high morbidity and mortality. We have previously demo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71ab6f908a933ef942fe17d46b20e1fe
https://doi.org/10.1016/j.cardfail.2019.07.185
https://doi.org/10.1016/j.cardfail.2019.07.185
Autor:
Jason S, Fritz, K Akaya, Smith
Publikováno v:
Chest. 150(3)
Pulmonary hypertension (PH) is an increasingly recognized cause of morbidity and mortality, and in the past 20 years, there has been a rapid expansion in research and available therapies. Although it is defined quite simply as a mean pulmonary arteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f94f5bc17546065f8f5bf2b090327fd4
https://pubmed.ncbi.nlm.nih.gov/27189309
https://pubmed.ncbi.nlm.nih.gov/27189309